Carl W. Langberg

  • Consultant
 

Publications 2018

Langberg MK, Berglund-Nord C, Cohn-Cedermark G, Haugnes HS, Tandstad T, Langberg CW (2018)
Imatinib may reduce chemotherapy-induced pneumonitis. A report on four cases from the SWENOTECA
Acta Oncol, 57 (10), 1401-1406
DOI 10.1080/0284186X.2018.1479072, PubMed 29869895

Publications 2016

Tandstad T, Ståhl O, Dahl O, Haugnes HS, Håkansson U, Karlsdottir Å, Kjellman A, Langberg CW, Laurell A, Oldenburg J, Solberg A, Söderström K, Stierner U, Cavallin-Ståhl E, Wahlqvist R, Wall N, Cohn-Cedermark G, SWENOTECA (2016)
Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: a report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA)
Ann Oncol, 27 (7), 1299-304
DOI 10.1093/annonc/mdw164, PubMed 27052649

Publications 2015

Nilsen TS, Raastad T, Skovlund E, Courneya KS, Langberg CW, Lilleby W, Fosså SD, Thorsen L (2015)
Effects of strength training on body composition, physical functioning, and quality of life in prostate cancer patients during androgen deprivation therapy
Acta Oncol, 54 (10), 1805-13
DOI 10.3109/0284186X.2015.1037008, PubMed 25927504

Oldenburg J, Haugnes HS, Dahl O, Karlsdottir Å, Langberg CW, Klepp O, Solberg A, Tandstad T (2015)
[Treatment for stage I-testicular cancer should be assessed individually]
Tidsskr Nor Laegeforen, 135 (15), 1340-1
DOI 10.4045/tidsskr.15.0544, PubMed 26315230

Publications 2014

Tandstad T, Ståhl O, Håkansson U, Dahl O, Haugnes HS, Klepp OH, Langberg CW, Laurell A, Oldenburg J, Solberg A, Söderström K, Cavallin-Ståhl E, Stierner U, Wahlquist R, Wall N, Cohn-Cedermark G, SWENOTECA (2014)
One course of adjuvant BEP in clinical stage I nonseminoma mature and expanded results from the SWENOTECA group
Ann Oncol, 25 (11), 2167-72
DOI 10.1093/annonc/mdu375, PubMed 25114021

Publications 2013

Karlsson R, Andreassen KE, Kristiansen W, Aschim EL, Bremnes RM, Dahl O, Fosså SD, Klepp O, Langberg CW, Solberg A, Tretli S, Magnusson PK, Adami HO, Haugen TB, Grotmol T, Wiklund F (2013)
Investigation of six testicular germ cell tumor susceptibility genes suggests a parent-of-origin effect in SPRY4
Hum Mol Genet, 22 (16), 3373-80
DOI 10.1093/hmg/ddt188, PubMed 23640991

Publications 2012

Kristiansen W, Andreassen KE, Karlsson R, Aschim EL, Bremnes RM, Dahl O, Fosså SD, Klepp O, Langberg CW, Solberg A, Tretli S, Adami HO, Wiklund F, Grotmol T, Haugen TB (2012)
Gene variations in sex hormone pathways and the risk of testicular germ cell tumour: a case-parent triad study in a Norwegian-Swedish population
Hum Reprod, 27 (5), 1525-35
DOI 10.1093/humrep/des075, PubMed 22402210

Publications 2011

Olofsson SE, Tandstad T, Jerkeman M, Dahl O, Ståhl O, Klepp O, Bremnes RM, Cohn-Cedermark G, Langberg CW, Laurell A, Solberg A, Stierner U, Wahlqvist R, Wijkström H, Anderson H, Cavallin-Ståhl E (2011)
Population-based study of treatment guided by tumor marker decline in patients with metastatic nonseminomatous germ cell tumor: a report from the Swedish-Norwegian Testicular Cancer Group
J Clin Oncol, 29 (15), 2032-9
DOI 10.1200/JCO.2010.29.1278, PubMed 21482994

Rogne SG, Rønning P, Helseth E, Johannesen TB, Langberg CW, Lote K, Scheie D, Meling TR (2011)
Craniotomy for brain metastases: a consecutive series of 316 patients
Acta Neurol Scand, 126 (1), 23-31
DOI 10.1111/j.1600-0404.2011.01590.x, PubMed 21902675

Skaali T, Fosså SD, Andersson S, Cvancarova M, Langberg CW, Lehne G, Dahl AA (2011)
Self-reported cognitive problems in testicular cancer patients: relation to neuropsychological performance, fatigue, and psychological distress
J Psychosom Res, 70 (5), 403-10
DOI 10.1016/j.jpsychores.2010.12.004, PubMed 21511070

Tandstad T, Smaaland R, Solberg A, Bremnes RM, Langberg CW, Laurell A, Stierner UK, Ståhl O, Cavallin-Ståhl EK, Klepp OH, Dahl O, Cohn-Cedermark G (2011)
Management of seminomatous testicular cancer: a binational prospective population-based study from the Swedish norwegian testicular cancer study group
J Clin Oncol, 29 (6), 719-25
DOI 10.1200/JCO.2010.30.1044, PubMed 21205748

Publications 2010

Haugnes HS, Wethal T, Aass N, Dahl O, Klepp O, Langberg CW, Wilsgaard T, Bremnes RM, Fosså SD (2010)
Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study
J Clin Oncol, 28 (30), 4649-57
DOI 10.1200/JCO.2010.29.9362, PubMed 20855830

Helseth R, Helseth E, Johannesen TB, Langberg CW, Lote K, Rønning P, Scheie D, Vik A, Meling TR (2010)
Overall survival, prognostic factors, and repeated surgery in a consecutive series of 516 patients with glioblastoma multiforme
Acta Neurol Scand, 122 (3), 159-67
DOI 10.1111/j.1600-0404.2010.01350.x, PubMed 20298491

Server A, Josefsen R, Kulle B, Maehlen J, Schellhorn T, Gadmar Ø, Kumar T, Haakonsen M, Langberg CW, Nakstad PH (2010)
Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors
Acta Radiol, 51 (3), 316-25
DOI 10.3109/02841850903482901, PubMed 20092374

Skaali T, Fosså SD, Andersson S, Cvancarova M, Langberg CW, Lehne G, Dahl AA (2010)
A prospective study of neuropsychological functioning in testicular cancer patients
Ann Oncol, 22 (5), 1062-70
DOI 10.1093/annonc/mdq553, PubMed 21048038

Skaali T, Fosså SD, Andersson S, Langberg CW, Lehne G, Dahl AA (2010)
Is psychological distress in men recently diagnosed with testicular cancer associated with their neuropsychological test performance?
Psychooncology, 20 (4), 369-77
DOI 10.1002/pon.1737, PubMed 20878832

Publications 2009

Server A, Kulle B, Maehlen J, Josefsen R, Schellhorn T, Kumar T, Langberg CW, Nakstad PH (2009)
Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema
Acta Radiol, 50 (6), 682-9
DOI 10.1080/02841850902933123, PubMed 19449234

Tandstad T, Dahl O, Cohn-Cedermark G, Cavallin-Stahl E, Stierner U, Solberg A, Langberg C, Bremnes RM, Laurell A, Wijkstrøm H, Klepp O (2009)
Risk-adapted treatment in clinical stage I nonseminomatous germ cell testicular cancer: the SWENOTECA management program
J Clin Oncol, 27 (13), 2122-8
DOI 10.1200/JCO.2008.18.8953, PubMed 19307506

Publications 2000

Denham JW, Hauer-Jensen M, Kron T, Langberg CW (2000)
Treatment-time-dependence models of early and delayed radiation injury in rat small intestine
Int J Radiat Oncol Biol Phys, 48 (3), 871-87
DOI 10.1016/S0360-3016(00)00708-2, PubMed 11020586

Langberg CW, Solheim S, Hagen S (2000)
[Can radiotherapy reduce the frequency of restenosis after coronary angioplasty?]
Tidsskr Nor Laegeforen, 120 (6), 707-10
PubMed 10806885

Publications 1999

Bakken AM, Ogreid P, Iversen J, Langberg CW (1999)
[Normal tissue radiation toxicity in radiotherapy of localized prostatic cancer]
Tidsskr Nor Laegeforen, 119 (14), 2017-21
PubMed 10394276

Publications 1997

Jensen JL, Langberg CW (1997)
[Temporary radiation-induced hypo-salivation in a child]
Tidsskr Nor Laegeforen, 117 (21), 3077-9
PubMed 9381440

Richter KK, Langberg CW, Sung CC, Hauer-Jensen M (1997)
Increased transforming growth factor beta (TGF-beta) immunoreactivity is independently associated with chronic injury in both consequential and primary radiation enteropathy
Int J Radiat Oncol Biol Phys, 39 (1), 187-95
PubMed 9300754

Publications 1996

Allgood JW, Langberg CW, Sung CC, Hauer-Jensen M (1996)
Timing of concomitant boost irradiation affects incidence and severity of intestinal complications
Int J Radiat Oncol Biol Phys, 34 (2), 381-7
PubMed 8567339

Langberg CW, Hauer-Jensen M (1996)
Optimal interfraction interval to minimize small bowel radiation injury in treatment regimens with two fractions per day: an experimental study in a rat model
Radiother Oncol, 41 (3), 249-55
PubMed 9027941

Langberg CW, Hauer-Jensen M (1996)
Influence of fraction size on the development of late radiation enteropathy. An experimental study in the rat
Acta Oncol, 35 (1), 89-94
PubMed 8619946

Langberg CW, Sauer T, Reitan JB, Hauer-Jensen M (1996)
Relationship between intestinal fibrosis and histopathologic and morphometric changes in consequential and late radiation enteropathy
Acta Oncol, 35 (1), 81-7
DOI 10.3109/02841869609098484, PubMed 8619945

Richter KK, Langberg CW, Sung CC, Hauer-Jensen M (1996)
Association of transforming growth factor beta (TGF-beta) immunoreactivity with specific histopathologic lesions in subacute and chronic experimental radiation enteropathy
Radiother Oncol, 39 (3), 243-51
PubMed 8783401

Publications 1995

Scott BR, Langberg CW, Hauer-Jensen M (1995)
Models for estimating the risk of ulcers in the small intestine after localized single or fractionated irradiation
Br J Radiol, 68 (805), 49-57
DOI 10.1259/0007-1285-68-805-49, PubMed 7881883

Publications 1994

Langberg CW, Hauer-Jensen M, Sung CC, Kane CJ (1994)
Expression of fibrogenic cytokines in rat small intestine after fractionated irradiation
Radiother Oncol, 32 (1), 29-36
PubMed 7938676

Langberg CW, Sauer T, Reitan JB, Hauer-Jensen M (1994)
Influence of fractionation schedule on development of intestinal complications following localized irradiation. An experimental study in the rat
Acta Oncol, 33 (4), 403-8
DOI 10.3109/02841869409098436, PubMed 8018373

Langberg CW, Waldron JA, Baker ML, Hauer-Jensen M (1994)
Significance of overall treatment time for the development of radiation-induced intestinal complications. An experimental study in the rat
Cancer, 73 (10), 2663-8
PubMed 8174067

Publications 1992

Langberg CW, Sauer T, Reitan JB, Hauer-Jensen M (1992)
Tolerance of rat small intestine to localized single dose and fractionated irradiation
Acta Oncol, 31 (7), 781-7
DOI 10.3109/02841869209083871, PubMed 1476759

Publications 1984

Langberg CW, Barkve H, Tjørstad K (1984)
[Cryptococcus neoformans meningoencephalitis]
Tidsskr Nor Laegeforen, 104 (14), 968-70
PubMed 6087494

Page visits: 452